What is alemtuzumab (and what is it used for)?
Alemtuzumab is a monoclonal antibody drug. It binds to CD52, a protein found on the surface of many immune cells, and causes depletion of those cells. By reducing immune activity, it is used in certain autoimmune and related conditions. [1]
How does alemtuzumab work in the body?
Alemtuzumab targets CD52 on immune cells. After binding, it leads to immune-cell depletion, which can reduce harmful immune activity driving disease. [1]
What is the difference between alemtuzumab and other monoclonal antibodies for autoimmune disease?
Like other monoclonal antibodies, alemtuzumab is designed to target a specific molecule on cells (CD52 in this case). Other antibody drugs target different immune pathways or cell markers, so their side effects, dosing schedules, and suitability can differ. [1]
What are the key safety concerns people ask about?
Patients often ask about risks related to immune-cell depletion, including infections and immune-related complications. Any specific risk profile depends on the exact condition being treated and the dosing/monitoring plan used by clinicians. [1]
How is alemtuzumab given?
Alemtuzumab is administered by healthcare professionals as an infusion as part of a treatment program that includes monitoring. The exact regimen depends on the indication. [1]
Is alemtuzumab a brand-name drug? Who makes it?
Alemtuzumab is the generic name; brand formulations and manufacturers can vary by country and indication. [1]
Sources
- https://www.drugs.com/alemtuzumab.html